Canada markets closed

Iterum Therapeutics plc (ITRM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.6500+0.0300 (+1.85%)
At close: 04:00PM EDT
1.6500 0.00 (0.00%)
After hours: 07:32PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 21.04M
Enterprise Value -24.29M
Trailing P/E 11.47
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.48
Enterprise Value/Revenue 105.22
Enterprise Value/EBITDA 7.69

Trading Information

Stock Price History

Beta (5Y Monthly) 1.25
52-Week Change 3-80.75%
S&P500 52-Week Change 3-16.62%
52 Week High 311.2500
52 Week Low 31.5800
50-Day Moving Average 32.7950
200-Day Moving Average 34.3262

Share Statistics

Avg Vol (3 month) 3285.53k
Avg Vol (10 day) 362.86k
Shares Outstanding 512.23M
Implied Shares Outstanding 6N/A
Float 812.15M
% Held by Insiders 10.71%
% Held by Institutions 14.09%
Shares Short (Sept 14, 2022) 4155.6k
Short Ratio (Sept 14, 2022) 41.15
Short % of Float (Sept 14, 2022) 41.29%
Short % of Shares Outstanding (Sept 14, 2022) 41.27%
Shares Short (prior month Aug 14, 2022) 4112.57k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Aug 17, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-18.56%
Return on Equity (ttm)-23.44%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -24.33M
Net Income Avi to Common (ttm)-10.68M
Diluted EPS (ttm)0.1400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)68.91M
Total Cash Per Share (mrq)5.63
Total Debt (mrq)25.6M
Total Debt/Equity (mrq)58.33
Current Ratio (mrq)9.47
Book Value Per Share (mrq)3.59

Cash Flow Statement

Operating Cash Flow (ttm)-16.04M
Levered Free Cash Flow (ttm)-26.96M